Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/182720
Title: | Thymoma and Autoimmune Encephalitis: Clinical Manifestations and Antibodies |
Author: | Guasp, Mar Landa, Jon Martínez Hernández, Eugenia Sabater, Lidia Iizuka, Takahiro Simabukuro, Mateus Nakamura, Masataka Kinoshita, Makoto Kaida, Kenichi Bruna, Jordi Kapetanovic, Solange Sánchez, Pedro Ruiz García, Raquel Naranjo, Laura Planagumà, Jesús Muñoz Lopetegi, Amaia Bataller, Luis Saiz, Albert Dalmau Obrador, Josep Graus Ribas, Francesc Kurihara, Masanori |
Keywords: | Encefalitis Estudi de casos Immunologia Encephalitis Case studies Immunology |
Issue Date: | 23-Jul-2021 |
Abstract: | To report the clinical, neuroimaging, and antibody associations in patients with autoimmune encephalitis (AE) and thymoma.A retrospective cohort study of 43 patients was conducted. Antibody determination and immunoprecipitation to characterize novel antigens were performed using reported techniques.Patients' median age was 52 years (range: 23-88 years). Forty (93%) had neuronal surface antibodies: gamma-aminobutyric acid receptor A (GABAAR) (15), amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (13), contactin-associated protein-like 2 (CASPR2) (4), leucine-rich, glioma inactivated 1 (LGI1) (3), glycine receptor (GlyR) (3), and unknown antigens (2). Concurrent antibodies against intracellular antigens occurred in 13 (30%; 9 anti-collapsin response mediator protein 5 [CRMP5]) and were more frequent in anti-AMPAR encephalitis (54% vs 20%; p = 0.037). The most common clinical presentation was encephalitis with multiple T2/fluid-attenuated inversion recovery hyperintense lesions in 23 (53%) patients (15 GABAAR, 5 AMPAR, and 1 unknown neuropil antibody), followed by encephalitis with peripheral nerve hyperexcitability in 7 (16%; 4 CASPR2, 2 LGI1, and 1 unknown antibody), limbic encephalitis in 6 (14%; 4 AMPAR, 1 LGI1, and 1 antibody negative), progressive encephalomyelitis with rigidity and myoclonus in 4 (9%; 3 GlyR and 1 AMPAR antibodies), and encephalitis with normal MRI in 3 (7%; AMPAR antibodies). Anti-GABAAR encephalitis was more prevalent in Japanese patients compared with Caucasians and other ethnicities (61% vs 16%; p = 0.003). In anti-AMPAR encephalitis, 3/4 patients with poor and 0/6 with good outcome had concurrent CRMP5 antibodies (p = 0.033). Immunoprecipitation studies identified metabotropic glutamate receptor 3 antibodies that were additionally found in 5 patients (3 with and 2 without encephalitis).AE in patients with thymoma include several clinical-radiologic syndromes that vary according to the associated antibodies. Anti-GABAAR encephalitis was the most frequent AE and occurred more frequently in Japanese patients. |
Note: | Reproducció del document publicat a: https://doi.org/10.1212/nxi.0000000000001053 |
It is part of: | Neurology-Neuroimmunology & Neuroinflammation, 2021, vol. 8, num. 5, p. e1053 |
URI: | http://hdl.handle.net/2445/182720 |
Related resource: | https://doi.org/10.1212/nxi.0000000000001053 |
ISSN: | 2332-7812 |
Appears in Collections: | Articles publicats en revistes (Institut de Neurociències (UBNeuro)) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Medicina) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
12474_9274278_thymomae1053.full.pdf | 493.55 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License